Alps Advisors Inc Prothena Corp Public LTD CO Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

A detailed history of Alps Advisors Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Alps Advisors Inc holds 41,627 shares of PRTA stock, worth $583,194. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,627
Previous 41,935 0.73%
Holding current value
$583,194
Previous $865,000 19.54%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$16.73 - $24.79 $5,152 - $7,635
-308 Reduced 0.73%
41,627 $696,000
Q2 2024

Aug 13, 2024
BUY
$19.54 - $26.15 $79,058 - $105,802
4,046 Added 10.68%
41,935 $865,000
Q1 2024

May 14, 2024
BUY
$24.75 - $40.66 $33,635 - $55,256
1,359 Added 3.72%
37,889 $938,000
Q4 2023

Feb 14, 2024
SELL
$32.31 - $52.32 $96,736 - $156,646
-2,994 Reduced 7.58%
36,530 $1.33 Million
Q3 2023

Nov 14, 2023
BUY
$47.3 - $70.6 $35,380 - $52,808
748 Added 1.93%
39,524 $1.91 Million
Q2 2023

Aug 14, 2023
BUY
$48.26 - $78.59 $199,892 - $325,519
4,142 Added 11.96%
38,776 $2.65 Million
Q1 2023

May 10, 2023
BUY
$46.97 - $58.27 $87,270 - $108,265
1,858 Added 5.67%
34,634 $1.68 Million
Q4 2022

Feb 14, 2023
BUY
$52.05 - $65.0 $374,031 - $467,090
7,186 Added 28.08%
32,776 $1.97 Million
Q3 2022

Nov 14, 2022
SELL
$25.16 - $60.63 $54,848 - $132,173
-2,180 Reduced 7.85%
25,590 $1.55 Million
Q2 2022

Aug 11, 2022
SELL
$22.73 - $39.98 $459,418 - $808,075
-20,212 Reduced 42.12%
27,770 $754,000
Q1 2022

May 16, 2022
SELL
$30.27 - $49.22 $179,682 - $292,169
-5,936 Reduced 11.01%
47,982 $1.76 Million
Q4 2021

Feb 09, 2022
SELL
$42.11 - $73.26 $54,237 - $94,358
-1,288 Reduced 2.33%
53,918 $2.66 Million
Q3 2021

Nov 15, 2021
SELL
$48.2 - $78.89 $128,886 - $210,951
-2,674 Reduced 4.62%
55,206 $3.93 Million
Q2 2021

Aug 11, 2021
SELL
$21.63 - $57.65 $310,109 - $826,528
-14,337 Reduced 19.85%
57,880 $2.98 Million
Q1 2021

May 07, 2021
BUY
$11.0 - $28.24 $869 - $2,230
79 Added 0.11%
72,217 $1.81 Million
Q4 2020

Feb 03, 2021
BUY
$10.12 - $13.94 $730,036 - $1.01 Million
72,138 New
72,138 $866,000

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $657M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email